UnitedHealth Group IncorporatedUnitedHealth raised its 2026 EPS outlook and reported improved margins, signaling strong financial performance.
UnitedHealth Group is shifting its Medicare Advantage strategy to prioritize profitability over membership expansion, expecting 2026 enrollment to decline by approximately 1.1 million members due to targeted exits from unprofitable plans. Medicare margins are now expected to finish the year above 3%, reflecting tighter benefit design, pricing actions, and a more favorable membership mix, while the company expects Medicare medical cost trends to come below the initial estimate of near 10%. UnitedHealth's consolidated medical care ratio improved to 86.7% in the second quarter from 89.4% a year ago, and the company raised its 2026 adjusted EPS outlook to $19.50-$20. The Zacks Consensus Estimate for UnitedHealth's 2026 earnings is pegged at $19.69 per share, implying 20.4% growth from the year-ago period, and the stock currently carries a Zacks Rank #1 (Strong Buy).
UnitedHealth Group IncorporatedUnitedHealth raised its 2026 EPS outlook and reported improved margins, signaling strong financial performance.
Humana IncHumana faces competitive pressure as UnitedHealth exits unprofitable plans, potentially reshaping the market and affecting Humana's positioning.
Elevance Health IncUnitedHealth's strategic shift to prioritize profitability may pressure competitors like Elevance to follow suit, potentially impacting their growth.